Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P70428

Entry ID Method Resolution Chain Position Source
AF-P70428-F1 Predicted AlphaFoldDB

32 variants for P70428

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388569245 28 T>P No EVA
rs256111826 73 T>A No EVA
rs3388569575 96 C>* No EVA
rs3388571617 101 K>N No EVA
rs3388567422 110 P>S No EVA
rs3388569594 113 K>R No EVA
rs3412659356 121 P>L No EVA
rs3388573802 139 D>G No EVA
rs3388567446 146 D>V No EVA
rs3388573618 168 K>N No EVA
rs3388572805 189 F>L No EVA
rs3388571362 199 Y>* No EVA
rs3388571651 226 Y>F No EVA
rs3388573827 238 A>T No EVA
rs3388571351 299 R>H No EVA
rs27397950 313 Q>R No EVA
rs3388574847 320 V>I No EVA
rs3388572790 334 V>D No EVA
rs3413075937 386 E>D No EVA
rs3388567420 398 A>G No EVA
rs3388566137 434 A>D No EVA
rs3388567479 511 V>A No EVA
rs3388571564 528 E>K No EVA
rs3388569593 529 I>F No EVA
rs13476641 622 T>A No EVA
rs3388567219 628 D>H No EVA
rs3391760597 636 A>T No EVA
rs3388566138 648 P>T No EVA
rs3388569590 651 K>N No EVA
rs3388566109 670 M>I No EVA
rs3388569581 691 V>L No EVA
rs3388571480 691 V>SDG* No EVA

No associated diseases with P70428

11 regional properties for P70428

Type Name Position InterPro Accession
repeat Tetratricopeptide repeat 1 246 - 279 IPR001440-1
repeat Tetratricopeptide repeat 1 642 - 672 IPR001440-2
repeat Tetratricopeptide repeat 213 - 246 IPR019734-1
repeat Tetratricopeptide repeat 246 - 279 IPR019734-2
repeat Tetratricopeptide repeat 280 - 313 IPR019734-3
repeat Tetratricopeptide repeat 430 - 463 IPR019734-4
repeat Tetratricopeptide repeat 472 - 505 IPR019734-5
repeat Tetratricopeptide repeat 506 - 539 IPR019734-6
repeat Tetratricopeptide repeat 606 - 639 IPR019734-7
repeat Tetratricopeptide repeat 640 - 673 IPR019734-8
domain RNA-polymerase II-associated protein 3-like, C-terminal domain 777 - 869 IPR025986

Functions

Description
EC Number 2.4.1.224 Hexosyltransferases
Subcellular Localization
  • Golgi apparatus membrane ; Single-pass type II membrane protein
  • Golgi apparatus, cis-Golgi network membrane ; Single-pass type II membrane protein
  • Endoplasmic reticulum membrane ; Single-pass type II membrane protein
  • Secreted
  • The active heparan sulfate polymerase complex composed of EXT1 and EXT2 is localized to the Golgi apparatus
  • If both proteins are individually detected in the endoplasmic reticulum, the formation of the complex promotes their transport to the Golgi
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
UDP-N-acetylglucosamine transferase complex A multienzyme, heterooligomeric complex involved in dolichyl-linked oligosaccharide synthesis. In yeast the complex is composed of Alg7p, which catalyzes the first step (GlcNAc1-PP-Dol from dolichol-phosphate and UDP-GlcNAc), and Alg13p plus Alg14p, the catalytic and anchoring subunits respectively, which together catalyze the second step (GlcNAc2-PP-dolichol from GlcNAc1-PP-Dol and UDP-GlcNAc) of dolichyl-linked oligosaccharide synthesis.

9 GO annotations of molecular function

Name Definition
acetylglucosaminyltransferase activity Catalysis of the transfer of an N-acetylglucosaminyl residue from UDP-N-acetyl-glucosamine to a sugar.
glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity Catalysis of the reaction: beta-D-glucuronosyl-(1,4)-N-acetyl-alpha-D-glucosaminyl-proteoglycan + UDP-N-acetyl-D-glucosamine = N-acetyl-alpha-D-glucosaminyl-(1,4)-beta-D-glucuronosyl-(1,4)-N-acetyl-alpha-D-glucosaminyl-proteoglycan + UDP.
glucuronosyltransferase activity Catalysis of the reaction: UDP-glucuronate + acceptor = UDP + acceptor beta-D-glucuronoside.
glycosyltransferase activity Catalysis of the transfer of a glycosyl group from one compound (donor) to another (acceptor).
heparan sulfate N-acetylglucosaminyltransferase activity Catalysis of the reaction: UDP-N-acetyl-D-glucosamine + heparan sulfate = UDP + (N-acetyl-D-glucosaminyl)-heparan sulfate.
metal ion binding Binding to a metal ion.
N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity Catalysis of the reaction: N-acetyl-alpha-D-glucosaminyl-(1,4)-beta-D-glucuronosyl-proteoglycan + UDP-alpha-D-glucuronate = beta-D-glucuronosyl-(1,4)-N-acetyl-alpha-D-glucosaminyl-(1,4)-beta-D-glucuronosyl-proteoglycan + UDP.
protein heterodimerization activity Binding to a nonidentical protein to form a heterodimer.
protein homodimerization activity Binding to an identical protein to form a homodimer.

19 GO annotations of biological process

Name Definition
cellular polysaccharide biosynthetic process The chemical reactions and pathways resulting in the formation of polysaccharides, polymers of many (typically more than 10) monosaccharide residues linked glycosidically, occurring at the level of an individual cell.
cellular response to fibroblast growth factor stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an fibroblast growth factor stimulus.
chondrocyte differentiation The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
endochondral bone morphogenesis The process in which bones are generated and organized as a result of the conversion of initial cartilaginous anlage into bone.
fluid transport The directed movement of substances that are in liquid form in normal living conditions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
gene expression The process in which a gene's sequence is converted into a mature gene product (protein or RNA). This includes the production of an RNA transcript and its processing, translation and maturation for protein-coding genes.
glycosaminoglycan biosynthetic process The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars.
heart contraction The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
heparan sulfate proteoglycan biosynthetic process The chemical reactions and pathways resulting in the formation of the heparan sulfate proteoglycan, a glycosaminoglycan with repeat unit consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues; the former are a mixture of sulfated and nonsulfated D-glucuronic acid and L-iduronic acid; the L-iduronic acid is either sulfated or acetylated on its amino group as well as being sulfated on one of its hydroxyl groups; heparan sulfate chains are covalently linked to peptidyl-serine by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylosyl to serine residues.
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process The chemical reactions and pathways resulting in the formation of polysaccharide chain component of heparan sulfate proteoglycan.
heparin biosynthetic process The chemical reactions and pathways resulting in the formation of heparin, any member of a group of glycosaminoglycans of average Mr (6000-20000), consisting predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
mesoderm formation The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
multicellular organismal water homeostasis Any process involved in the maintenance of an internal steady state of water within a tissue, organ, or a multicellular organism.
ossification The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
protein N-linked glycosylation A protein glycosylation process in which a carbohydrate or carbohydrate derivative unit is added to a protein via the N4 atom of peptidyl-asparagine, the omega-N of arginine, or the N1' atom peptidyl-tryptophan.
regulation of blood pressure Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
sodium ion homeostasis Any process involved in the maintenance of an internal steady state of sodium ions within an organism or cell.
sulfation The addition of a sulfate group to a molecule.
vasodilation An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure.

8 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O77783 EXT2 Exostosin-2 Bos taurus (Bovine) PR
Q9Y169 sotv Exostosin-2 Drosophila melanogaster (Fruit fly) PR
Q9ES89 Extl2 Exostosin-like 2 Mus musculus (Mouse) PR
P97464 Ext1 Exostosin-1 Mus musculus (Mouse) PR
Q9WVL6 Extl3 Exostosin-like 3 Mus musculus (Mouse) PR
Q94AA9 XGD1 Xylogalacturonan beta-1,3-xylosyltransferase Arabidopsis thaliana (Mouse-ear cress) PR
Q9LFP3 At5g11130/At5g11120 Probable glycosyltransferase At5g11130 Arabidopsis thaliana (Mouse-ear cress) PR
Q3EAR7 At3g42180 Probable glycosyltransferase At3g42180 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MCASVKSNIR GPALIPRMKT KHRIYYVTLF SIVLLGLIAT GMFQFWPHSI ESSSDGGVEK
70 80 90 100 110 120
RSIREVPVVR LPTDSPIPER GDLSCRMHTC FDVYRCGFNP KNKIKVYIYP LKKYVDDAGV
130 140 150 160 170 180
PVSSAISREY NELLTAISDS DYYTDDINRA CLFVPSIDVL NQNPLRIKET AQALAQLSRW
190 200 210 220 230 240
DRGTNHLLFN MLPGAPPDYN TALDVPRDRA LLAGGGFSTW TYRQGYDVSI PVFSPLSAEM
250 260 270 280 290 300
ALPEKAPGPR RYFLLSSQMA IHPEYREELE ALQAKHQESV LVLDKCTNLS EGVLSVRKRC
310 320 330 340 350 360
HQHQVFDYPQ VLQEATFCTV LRGARLGQAV LSDVLQAGCV PVVIADSYIL PFSEVLDWKR
370 380 390 400 410 420
ASVVVPEEKM SDVYSILQNI PQRQIEEMQR QARWFWEAYF QSIKAIALAT LQIINDRIYP
430 440 450 460 470 480
YAAISYEEWN DPPAVKWASV SNPLFLPLIP PQSQGFTAIV LTYDRVESLF RVITEVSKVP
490 500 510 520 530 540
SLSKLLVVWN NQNKNPPEES LWPKIRVPLK VVRTAENKLS NRFFPYDEIE TEAVLAIDDD
550 560 570 580 590 600
IIMLTSDELQ FGYEVWREFP DRLVGYPGRL HLWDHEMNKW KYESEWTNEV SMVLTGAAFY
610 620 630 640 650 660
HKYFNYLYTY KMPGDIKNWV DTHMNCEDIA MNFLVANVTG KAVIKVTPRK KFKCPECTAI
670 680 690 700 710
DGLSLDQTHM VERSECINKF ASVFGTMPLK VVEHRADPVL YKDDFPEKLK SFPNIGSL